Back
Loblaw Companies Vs. ANI Pharmaceuticals Industry Stock Comparison
Buy
56
LBLCF
Loblaw Companies
Last Price:
133.51
Seasonality Move:
2.74%
Sell
46
ANIP
ANI Pharmaceuticals
Last Price:
61.01
Seasonality Move:
5.08%
Buy
56
Loblaw Companies (LBLCF)
is a Buy
Is Loblaw Companies a Buy, Sell or Hold?
- The current Loblaw Companies [LBLCF] share price is $133.51. The Score for LBLCF is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- LBLCF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
ANI Pharmaceuticals (ANIP)
is a Sell
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.85. The Score for ANIP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- ANIP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LBLCF Stock Price Chart
What is Loblaw Companies's stock price today?
-
The Loblaw Companies share price today is $133.51
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LBLCF is experiencing selling pressure, which indicates risk of future bearish movement.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.85
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing buying pressure, which is a positive indicator for future bullish movement.
LBLCF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.18 | Buy |
| Relative Strength Index (14 RSI): | 70.99 | Buy |
| Chaikin Money Flow: | -300 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (125.35 - 130.69) | Buy |
| Bollinger Bands (100): | (119.99 - 129.93) | Buy |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 60.98 | Buy |
| Chaikin Money Flow: | 213168 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.73 - 59.99) | Buy |
| Bollinger Bands (100): | (57.71 - 62.95) | Buy |
LBLCF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 129.95 | Buy |
| 20-day SMA: | 127.92 | Buy |
| 50-day SMA: | 128.62 | Buy |
| 200-day SMA: | 117.37 | Buy |
| 8-day EMA: | 130.84 | Buy |
| 20-day EMA: | 128.99 | Buy |
| 50-day EMA: | 127.64 | Buy |
| 200-day EMA: | 117.58 | Buy |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.64 | Buy |
| 20-day SMA: | 58.88 | Buy |
| 50-day SMA: | 58.7 | Buy |
| 200-day SMA: | 62.08 | Sell |
| 8-day EMA: | 59.48 | Buy |
| 20-day EMA: | 58.83 | Buy |
| 50-day EMA: | 59.09 | Buy |
| 200-day EMA: | 59.9 | Buy |
Loblaw Companies Earnings Growth & LBLCF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and an increase next year of $0.49 per share.
Loblaw Companies Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||